Process View
The directed movement of a mature natural killer cell guided by a specific chemical concentration gradient. Movement may be towards a higher concentration (positive chemotaxis) or towards a lower concentration (negative chemotaxis). A mature natural killer cell is a natural killer cell that is developmentally mature and expresses a variety of inhibitory and activating receptors that recognize MHC class and other stress related molecules.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "mature natural killer cell chemotaxis"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| CCR5 | chemokine (C-C motif) receptor 5 | 1.000 | ||
| CCL4 | chemokine (C-C motif) ligand 4 | 1.000 | Human | |
| CCL2 | chemokine (C-C motif) ligand 2 | 1.000 | Human | |
| CCL5 | chemokine (C-C motif) ligand 5 | 1.000 | Human | |
| CXCL9 | chemokine (C-X-C motif) ligand 9 | 1.000 | ||
| IL8 | interleukin 8 | 1.000 | ||
| IL1B | interleukin 1, beta | 0.997 | ||
| CXCL10 | chemokine (C-X-C motif) ligand 10 | 0.996 | ||
| CXCL2 | chemokine (C-X-C motif) ligand 2 | 0.996 | ||
| CCL8 | chemokine (C-C motif) ligand 8 | 0.994 | Human | |
| IL6 | interleukin 6 (interferon, beta 2) | 0.987 | ||
| CCL18 | chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated) | 0.986 | Human | |
| CXCL1 | chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) | 0.985 | ||
| CXCL3 | chemokine (C-X-C motif) ligand 3 | 0.977 | ||
| CCL22 | chemokine (C-C motif) ligand 22 | 0.976 | Human | |
| DPP4 | dipeptidyl-peptidase 4 | 0.975 | ||
| CCR7 | chemokine (C-C motif) receptor 7 | 0.969 | ||
| CXCL11 | chemokine (C-X-C motif) ligand 11 | 0.964 | ||
| ICAM1 | intercellular adhesion molecule 1 | 0.942 | ||
| IDE | insulin-degrading enzyme | 0.924 | ||
| CCL13 | chemokine (C-C motif) ligand 13 | 0.909 | Human | |
| PTGS2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) | 0.879 | ||
| CCL19 | chemokine (C-C motif) ligand 19 | 0.862 | Human | |
| CCL3 | chemokine (C-C motif) ligand 3 | 0.843 | Human | |
| TNF | tumor necrosis factor | 0.835 | ||
| IFNG | interferon, gamma | 0.824 | ||
| CXCL13 | chemokine (C-X-C motif) ligand 13 | 0.808 | ||
| CD83 | CD83 molecule | 0.806 | ||
| VCAM1 | vascular cell adhesion molecule 1 | 0.798 | ||
| TRAF1 | TNF receptor-associated factor 1 | 0.763 | ||
| TNFRSF9 | tumor necrosis factor receptor superfamily, member 9 | 0.742 | ||
| CCL20 | chemokine (C-C motif) ligand 20 | 0.734 | Human | |
| RGS1 | regulator of G-protein signaling 1 | 0.724 | ||
| CCR1 | chemokine (C-C motif) receptor 1 | 0.703 | ||
| IL7R | interleukin 7 receptor | 0.687 | ||
| MMP12 | matrix metallopeptidase 12 (macrophage elastase) | 0.659 | ||
| TNFAIP3 | tumor necrosis factor, alpha-induced protein 3 | 0.634 | ||
| IL10 | interleukin 10 | 0.538 | ||
| CCL7 | chemokine (C-C motif) ligand 7 | 0.498 | Human | |
| SELE | selectin E | 0.493 | ||
| CCR4 | chemokine (C-C motif) receptor 4 | 0.489 | ||
| CXCL5 | chemokine (C-X-C motif) ligand 5 | 0.486 | ||
| IL2RB | interleukin 2 receptor, beta | 0.462 | ||
| BCL2A1 | BCL2-related protein A1 | 0.454 | ||
| UBD | ubiquitin D | 0.375 | ||
| CCL11 | chemokine (C-C motif) ligand 11 | 0.373 | Human | |
| IL1RN | interleukin 1 receptor antagonist | 0.351 | ||
| BIRC3 | baculoviral IAP repeat containing 3 | 0.334 | ||
| CXCL6 | chemokine (C-X-C motif) ligand 6 (granulocyte chemotactic protein 2) | 0.325 | ||
| SRGN | serglycin | 0.304 | ||
| TNFAIP6 | tumor necrosis factor, alpha-induced protein 6 | 0.279 | ||
| CH25H | cholesterol 25-hydroxylase | 0.270 | ||
| GZMB | granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) | 0.207 | ||
| FPR3 | formyl peptide receptor 3 | 0.192 | ||
| IL2RG | interleukin 2 receptor, gamma | 0.185 | ||
| CD69 | CD69 molecule | 0.177 | ||
| CD40 | CD40 molecule, TNF receptor superfamily member 5 | 0.175 | ||
| DARC | Duffy blood group, chemokine receptor | 0.166 | ||
| IDO1 | indoleamine 2,3-dioxygenase 1 | 0.161 | ||
| LAMP3 | lysosomal-associated membrane protein 3 | 0.158 | ||
| IL10RA | interleukin 10 receptor, alpha | 0.149 | ||
| MMP9 | matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) | 0.129 | ||
| EBI3 | Epstein-Barr virus induced 3 | 0.127 | ||
| ADAMDEC1 | ADAM-like, decysin 1 | 0.126 | ||
| CCL3L3 | chemokine (C-C motif) ligand 3-like 3 | 0.119 | ||
| PLEK | pleckstrin | 0.118 | ||
| IRF4 | interferon regulatory factor 4 | 0.105 | ||
| STAT4 | signal transducer and activator of transcription 4 | 0.104 | ||
| SLAMF8 | SLAM family member 8 | 0.096 | ||
| SOD2 | superoxide dismutase 2, mitochondrial | 0.094 | ||
| SLAMF7 | SLAM family member 7 | 0.091 | ||
| IL18RAP | interleukin 18 receptor accessory protein | 0.088 | ||
| IL1R2 | interleukin 1 receptor, type II | 0.088 | ||
| AKT2 | v-akt murine thymoma viral oncogene homolog 2 | 0.084 | ||
| TNFRSF1B | tumor necrosis factor receptor superfamily, member 1B | 0.077 | ||
| IL21R | interleukin 21 receptor | 0.075 | ||
| IL12B | interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) | 0.072 | ||
| IL2RA | interleukin 2 receptor, alpha | 0.071 | ||
| OLR1 | oxidized low density lipoprotein (lectin-like) receptor 1 | 0.068 | ||
| ARRB1 | arrestin, beta 1 | 0.068 | ||
| CXCR3 | chemokine (C-X-C motif) receptor 3 | 0.067 | ||
| XCL1 | chemokine (C motif) ligand 1 | 0.064 | ||
| CXCR6 | chemokine (C-X-C motif) receptor 6 | 0.062 | ||
| RGS16 | regulator of G-protein signaling 16 | 0.060 | ||
| CCL21 | chemokine (C-C motif) ligand 21 | 0.056 | ||
| KLRB1 | killer cell lectin-like receptor subfamily B, member 1 | 0.049 | ||
| KLRD1 | killer cell lectin-like receptor subfamily D, member 1 | 0.048 | ||
| NR4A3 | nuclear receptor subfamily 4, group A, member 3 | 0.047 | ||
| MSC | musculin | 0.047 | ||
| CCR3 | chemokine (C-C motif) receptor 3 | 0.047 | ||
| LTA | lymphotoxin alpha (TNF superfamily, member 1) | 0.047 | ||
| XCL2 | chemokine (C motif) ligand 2 | 0.046 | Human | |
| HLA-DRB4 | major histocompatibility complex, class II, DR beta 4 | 0.043 | ||
| IL1A | interleukin 1, alpha | 0.041 | ||
| IL3 | interleukin 3 (colony-stimulating factor, multiple) | 0.040 | ||
| CCRL2 | chemokine (C-C motif) receptor-like 2 | 0.039 | ||
| PLA2G7 | phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma) | 0.036 | ||
| GNLY | granulysin | 0.035 | ||
| IL15RA | interleukin 15 receptor, alpha | 0.034 | ||
| CSF1 | colony stimulating factor 1 (macrophage) | 0.034 | ||
| SLAMF1 | signaling lymphocytic activation molecule family member 1 | 0.033 | ||
| HSD11B1 | hydroxysteroid (11-beta) dehydrogenase 1 | 0.033 | ||
| CCL23 | chemokine (C-C motif) ligand 23 | 0.032 | Human | |
| LIF | leukemia inhibitory factor (cholinergic differentiation factor) | 0.032 | ||
| IL18R1 | interleukin 18 receptor 1 | 0.032 | ||
| CCL17 | chemokine (C-C motif) ligand 17 | 0.031 | Human | |
| BATF | basic leucine zipper transcription factor, ATF-like | 0.030 | ||
| SIGLEC1 | sialic acid binding Ig-like lectin 1, sialoadhesin | 0.030 | ||
| CD80 | CD80 molecule | 0.029 | ||
| SLCO2B1 | solute carrier organic anion transporter family, member 2B1 | 0.029 | ||
| APOC1 | apolipoprotein C-I | 0.028 | ||
| C3AR1 | complement component 3a receptor 1 | 0.027 | ||
| TNFAIP2 | tumor necrosis factor, alpha-induced protein 2 | 0.027 | ||
| NKG7 | natural killer cell group 7 sequence | 0.027 | ||
| TNFRSF4 | tumor necrosis factor receptor superfamily, member 4 | 0.026 | ||
| CD163 | CD163 molecule | 0.026 | ||
| TLR2 | toll-like receptor 2 | 0.026 | ||
| GPR109B | G protein-coupled receptor 109B | 0.025 | ||
| CHI3L1 | chitinase 3-like 1 (cartilage glycoprotein-39) | 0.024 | ||
| NNMT | nicotinamide N-methyltransferase | 0.024 | ||
| C5AR1 | complement component 5a receptor 1 | 0.023 | ||
| SOCS3 | suppressor of cytokine signaling 3 | 0.023 | ||
| CD40LG | CD40 ligand | 0.022 | ||
| MMP10 | matrix metallopeptidase 10 (stromelysin 2) | 0.022 | ||
| C1R | complement component 1, r subcomponent | 0.022 | ||
| AQP9 | aquaporin 9 | 0.022 | ||
| SERPINB9 | serpin peptidase inhibitor, clade B (ovalbumin), member 9 | 0.021 | ||
| FEZ1 | fasciculation and elongation protein zeta 1 (zygin I) | 0.021 | ||
| PTX3 | pentraxin 3, long | 0.020 | ||
| TFEC | transcription factor EC | 0.020 | ||
| C2 | complement component 2 | 0.019 | ||
| INHBA | inhibin, beta A | 0.019 | ||
| RUNX3 | runt-related transcription factor 3 | 0.019 | ||
| RARRES1 | retinoic acid receptor responder (tazarotene induced) 1 | 0.019 | ||
| PDPN | podoplanin | 0.019 | ||
| DNASE1L3 | deoxyribonuclease I-like 3 | 0.019 | ||
| LRRC32 | leucine rich repeat containing 32 | 0.018 | ||
| CCL1 | chemokine (C-C motif) ligand 1 | 0.018 | Human | |
| IL13 | interleukin 13 | 0.018 | ||
| OSMR | oncostatin M receptor | 0.018 | ||
| MMP3 | matrix metallopeptidase 3 (stromelysin 1, progelatinase) | 0.017 | ||
| LAG3 | lymphocyte-activation gene 3 | 0.017 | ||
| C3 | complement component 3 | 0.017 | ||
| ZC3H12A | zinc finger CCCH-type containing 12A | 0.016 | ||
| CD48 | CD48 molecule | 0.016 | ||
| ICOS | inducible T-cell co-stimulator | 0.015 | ||
| CD209 | CD209 molecule | 0.015 | ||
| IL7 | interleukin 7 | 0.015 | ||
| MMP1 | matrix metallopeptidase 1 (interstitial collagenase) | 0.015 | ||
| SELP | selectin P (granule membrane protein 140kDa, antigen CD62) | 0.015 | ||
| CSF2 | colony stimulating factor 2 (granulocyte-macrophage) | 0.014 | ||
| PI3 | peptidase inhibitor 3, skin-derived | 0.014 | ||
| CXCR5 | chemokine (C-X-C motif) receptor 5 | 0.014 | ||
| G0S2 | G0/G1switch 2 | 0.014 | ||
| PRDM1 | PR domain containing 1, with ZNF domain | 0.014 | ||
| DUSP2 | dual specificity phosphatase 2 | 0.014 | ||
| GPR183 | G protein-coupled receptor 183 | 0.014 | ||
| SLC2A5 | solute carrier family 2 (facilitated glucose/fructose transporter), member 5 | 0.013 | ||
| SCARF1 | scavenger receptor class F, member 1 | 0.013 | ||
| PLA1A | phospholipase A1 member A | 0.013 | ||
| CD160 | CD160 molecule | 0.013 | ||
| NLRP3 | NLR family, pyrin domain containing 3 | 0.013 | ||
| DDX39A | DEAD (Asp-Glu-Ala-Asp) box polypeptide 39A | 0.013 | ||
| C1QB | complement component 1, q subcomponent, B chain | 0.013 | ||
| IL4 | interleukin 4 | 0.013 | ||
| PDCD1LG2 | programmed cell death 1 ligand 2 | 0.013 | ||
| HLA-DOA | major histocompatibility complex, class II, DO alpha | 0.013 | ||
| IL4I1 | interleukin 4 induced 1 | 0.013 | ||
| MMP19 | matrix metallopeptidase 19 | 0.013 | ||
| MMP7 | matrix metallopeptidase 7 (matrilysin, uterine) | 0.013 | ||
| CSF2RB | colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage) | 0.013 | ||
| CXCR4 | chemokine (C-X-C motif) receptor 4 | 0.012 | ||
| NFKBIE | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon | 0.012 | ||
| SAMSN1 | SAM domain, SH3 domain and nuclear localization signals 1 | 0.012 | ||
| TNIP3 | TNFAIP3 interacting protein 3 | 0.012 | ||
| TREM1 | triggering receptor expressed on myeloid cells 1 | 0.012 | ||
| CMKLR1 | chemokine-like receptor 1 | 0.012 | ||
| TYMP | thymidine phosphorylase | 0.012 | ||
| CHI3L2 | chitinase 3-like 2 | 0.012 | ||
| IL24 | interleukin 24 | 0.012 | ||
| CHIT1 | chitinase 1 (chitotriosidase) | 0.011 | ||
| CCBP2 | chemokine binding protein 2 | 0.011 | ||
| IL32 | interleukin 32 | 0.011 | ||
| GPR84 | G protein-coupled receptor 84 | 0.011 | ||
| CXCL12 | chemokine (C-X-C motif) ligand 12 | 0.011 | ||
| CST7 | cystatin F (leukocystatin) | 0.011 | ||
| CSF3 | colony stimulating factor 3 (granulocyte) | 0.011 | ||
| PLA2G2A | phospholipase A2, group IIA (platelets, synovial fluid) | 0.010 | ||
| EGR2 | early growth response 2 | 0.010 | ||
| IL12A | interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35) | 0.010 | ||
| CD86 | CD86 molecule | 0.010 | ||
| P2RY6 | pyrimidinergic receptor P2Y, G-protein coupled, 6 | 0.010 |